0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Veterinary Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Published Date: November 2022
|
Report Code: QYRE-Auto-19O6094
Home | Market Reports | Pets & Animals| Animal Products & Services| Veterinarians
Global and United States Veterinary Vaccines Market Report Forecast 2022 2028
BUY CHAPTERS

Global Veterinary Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Code: QYRE-Auto-19O6094
Report
November 2022
Pages:126
QYResearch
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
Vaccines play a crucial role in protecting animals from a large spectrum of diseases caused due to virus, bacteria, protozoa, and other multicellular pathogens.
Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Veterinary Vaccines estimated at US$ 7700.3 million in the year 2022, is projected to reach a revised size of US$ 11560 million by 2028, growing at a CAGR of 7.0% during the forecast period 2022-2028.

The global veterinary vaccines market is expected to benefit from the growing concern over food safety. The dependency on livestock products like meat, milk, and other products is increasing, and the mortality rate associated with infection transmission from animals to humans through these products is alarming. These factors are driving the vendors to invest in R&D to improve and expand their product portfolios, thereby driving the market growth.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Veterinary Vaccines companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Veterinary Vaccines market. Further, it explains the major drivers and regional dynamics of the global Veterinary Vaccines market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Elanco
Merck
Merial
Zoetis
Advaxis
AmpliPhi Biosciences
Aratana Therapeutics
ARKO Labs
Bayer
CanFel Therapeutics
Ceva Animal Health
Colorado Serum
Epitopix
Genus
Hygieia Biological Laboratories
ImmuCell
Nexvet
Nuovo Biologics
UBI
Valneva
Vetoquinol
Virbac
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Veterinary Vaccines Segment by Type

Inactivated Vaccines
Live Attenuated Vaccines
Conjugate Vaccines
Toxoid Vaccines
Recombinant Vaccines
DNA Vaccines
Others

Veterinary Vaccines Segment by Application

Veterinary Clinic
Veterinary Hospital
Veterinary Research Institute
Retail Pharmacy
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Veterinary Vaccines market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Veterinary Vaccines market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Veterinary Vaccines, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Veterinary Vaccines, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Veterinary Vaccines revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Veterinary Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Veterinary Vaccines revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Elanco, Merck, Merial, Zoetis, Advaxis, AmpliPhi Biosciences, Aratana Therapeutics, ARKO Labs and Bayer, etc.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Veterinary Vaccines Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Inactivated Vaccines
1.2.3 Live Attenuated Vaccines
1.2.4 Conjugate Vaccines
1.2.5 Toxoid Vaccines
1.2.6 Recombinant Vaccines
1.2.7 DNA Vaccines
1.2.8 Others
1.3 Market by Application
1.3.1 Global Veterinary Vaccines Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Veterinary Clinic
1.3.3 Veterinary Hospital
1.3.4 Veterinary Research Institute
1.3.5 Retail Pharmacy
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Veterinary Vaccines Market Size (2017-2028)
2.2 Veterinary Vaccines Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Veterinary Vaccines Market Size by Region (2017-2022)
2.4 Global Veterinary Vaccines Market Size Forecast by Region (2023-2028)
2.5 Global Top Veterinary Vaccines Countries Ranking by Market Size
3 Veterinary Vaccines Competitive by Company
3.1 Global Veterinary Vaccines Revenue by Players
3.1.1 Global Veterinary Vaccines Revenue by Players (2017-2022)
3.1.2 Global Veterinary Vaccines Market Share by Players (2017-2022)
3.2 Global Veterinary Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Veterinary Vaccines Revenue
3.4 Global Veterinary Vaccines Market Concentration Ratio
3.4.1 Global Veterinary Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Veterinary Vaccines Revenue in 2021
3.5 Global Veterinary Vaccines Key Players Head office and Area Served
3.6 Key Players Veterinary Vaccines Product Solution and Service
3.7 Date of Enter into Veterinary Vaccines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Veterinary Vaccines Breakdown Data by Type
4.1 Global Veterinary Vaccines Historic Revenue by Type (2017-2022)
4.2 Global Veterinary Vaccines Forecasted Revenue by Type (2023-2028)
5 Global Veterinary Vaccines Breakdown Data by Application
5.1 Global Veterinary Vaccines Historic Market Size by Application (2017-2022)
5.2 Global Veterinary Vaccines Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Veterinary Vaccines Revenue by Company (2020-2022)
6.2 North America Veterinary Vaccines Revenue by Type (2017-2028)
6.3 North America Veterinary Vaccines Revenue by Application (2017-2028)
6.4 North America Veterinary Vaccines Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Veterinary Vaccines Revenue by Company (2020-2022)
7.2 Europe Veterinary Vaccines Revenue by Type (2017-2028)
7.3 Europe Veterinary Vaccines Revenue by Application (2017-2028)
7.4 Europe Veterinary Vaccines Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Veterinary Vaccines Revenue by Company (2020-2022)
8.2 Asia Pacific Veterinary Vaccines Revenue by Type (2017-2028)
8.3 Asia Pacific Veterinary Vaccines Revenue by Application (2017-2028)
8.4 Asia Pacific Veterinary Vaccines Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Veterinary Vaccines Revenue by Company (2020-2022)
9.2 Latin America Veterinary Vaccines Revenue by Type (2017-2028)
9.3 Latin America Veterinary Vaccines Revenue by Application (2017-2028)
9.4 Latin America Veterinary Vaccines Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Veterinary Vaccines Revenue by Company (2020-2022)
10.2 Middle East and Africa Veterinary Vaccines Revenue by Type (2017-2028)
10.3 Middle East and Africa Veterinary Vaccines Revenue by Application (2017-2028)
10.4 Middle East and Africa Veterinary Vaccines Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 U.A.E
11 Company Profiles
11.1 Elanco
11.1.1 Elanco Company Details
11.1.2 Elanco Business Overview
11.1.3 Elanco Veterinary Vaccines Products and Services
11.1.4 Elanco Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022)
11.1.5 Elanco Veterinary Vaccines SWOT Analysis
11.1.6 Elanco Recent Developments
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Veterinary Vaccines Products and Services
11.2.4 Merck Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022)
11.2.5 Merck Veterinary Vaccines SWOT Analysis
11.2.6 Merck Recent Developments
11.3 Merial
11.3.1 Merial Company Details
11.3.2 Merial Business Overview
11.3.3 Merial Veterinary Vaccines Products and Services
11.3.4 Merial Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022)
11.3.5 Merial Veterinary Vaccines SWOT Analysis
11.3.6 Merial Recent Developments
11.4 Zoetis
11.4.1 Zoetis Company Details
11.4.2 Zoetis Business Overview
11.4.3 Zoetis Veterinary Vaccines Products and Services
11.4.4 Zoetis Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022)
11.4.5 Zoetis Veterinary Vaccines SWOT Analysis
11.4.6 Zoetis Recent Developments
11.5 Advaxis
11.5.1 Advaxis Company Details
11.5.2 Advaxis Business Overview
11.5.3 Advaxis Veterinary Vaccines Products and Services
11.5.4 Advaxis Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022)
11.5.5 Advaxis Veterinary Vaccines SWOT Analysis
11.5.6 Advaxis Recent Developments
11.6 AmpliPhi Biosciences
11.6.1 AmpliPhi Biosciences Company Details
11.6.2 AmpliPhi Biosciences Business Overview
11.6.3 AmpliPhi Biosciences Veterinary Vaccines Products and Services
11.6.4 AmpliPhi Biosciences Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022)
11.6.5 AmpliPhi Biosciences Veterinary Vaccines SWOT Analysis
11.6.6 AmpliPhi Biosciences Recent Developments
11.7 Aratana Therapeutics
11.7.1 Aratana Therapeutics Company Details
11.7.2 Aratana Therapeutics Business Overview
11.7.3 Aratana Therapeutics Veterinary Vaccines Products and Services
11.7.4 Aratana Therapeutics Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022)
11.7.5 Aratana Therapeutics Veterinary Vaccines SWOT Analysis
11.7.6 Aratana Therapeutics Recent Developments
11.8 ARKO Labs
11.8.1 ARKO Labs Company Details
11.8.2 ARKO Labs Business Overview
11.8.3 ARKO Labs Veterinary Vaccines Products and Services
11.8.4 ARKO Labs Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022)
11.8.5 ARKO Labs Veterinary Vaccines SWOT Analysis
11.8.6 ARKO Labs Recent Developments
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Bayer Business Overview
11.9.3 Bayer Veterinary Vaccines Products and Services
11.9.4 Bayer Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022)
11.9.5 Bayer Veterinary Vaccines SWOT Analysis
11.9.6 Bayer Recent Developments
11.10 CanFel Therapeutics
11.10.1 CanFel Therapeutics Company Details
11.10.2 CanFel Therapeutics Business Overview
11.10.3 CanFel Therapeutics Veterinary Vaccines Products and Services
11.10.4 CanFel Therapeutics Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022)
11.10.5 CanFel Therapeutics Veterinary Vaccines SWOT Analysis
11.10.6 CanFel Therapeutics Recent Developments
11.11 Ceva Animal Health
11.11.1 Ceva Animal Health Company Details
11.11.2 Ceva Animal Health Business Overview
11.11.3 Ceva Animal Health Veterinary Vaccines Products and Services
11.11.4 Ceva Animal Health Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022)
11.11.5 Ceva Animal Health Recent Developments
11.12 Colorado Serum
11.12.1 Colorado Serum Company Details
11.12.2 Colorado Serum Business Overview
11.12.3 Colorado Serum Veterinary Vaccines Products and Services
11.12.4 Colorado Serum Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022)
11.12.5 Colorado Serum Recent Developments
11.13 Epitopix
11.13.1 Epitopix Company Details
11.13.2 Epitopix Business Overview
11.13.3 Epitopix Veterinary Vaccines Products and Services
11.13.4 Epitopix Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022)
11.13.5 Epitopix Recent Developments
11.14 Genus
11.14.1 Genus Company Details
11.14.2 Genus Business Overview
11.14.3 Genus Veterinary Vaccines Products and Services
11.14.4 Genus Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022)
11.14.5 Genus Recent Developments
11.15 Hygieia Biological Laboratories
11.15.1 Hygieia Biological Laboratories Company Details
11.15.2 Hygieia Biological Laboratories Business Overview
11.15.3 Hygieia Biological Laboratories Veterinary Vaccines Products and Services
11.15.4 Hygieia Biological Laboratories Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022)
11.15.5 Hygieia Biological Laboratories Recent Developments
11.16 ImmuCell
11.16.1 ImmuCell Company Details
11.16.2 ImmuCell Business Overview
11.16.3 ImmuCell Veterinary Vaccines Products and Services
11.16.4 ImmuCell Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022)
11.16.5 ImmuCell Recent Developments
11.17 Nexvet
11.17.1 Nexvet Company Details
11.17.2 Nexvet Business Overview
11.17.3 Nexvet Veterinary Vaccines Products and Services
11.17.4 Nexvet Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022)
11.17.5 Nexvet Recent Developments
11.18 Nuovo Biologics
11.18.1 Nuovo Biologics Company Details
11.18.2 Nuovo Biologics Business Overview
11.18.3 Nuovo Biologics Veterinary Vaccines Products and Services
11.18.4 Nuovo Biologics Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022)
11.18.5 Nuovo Biologics Recent Developments
11.19 UBI
11.19.1 UBI Company Details
11.19.2 UBI Business Overview
11.19.3 UBI Veterinary Vaccines Products and Services
11.19.4 UBI Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022)
11.19.5 UBI Recent Developments
11.20 Valneva
11.20.1 Valneva Company Details
11.20.2 Valneva Business Overview
11.20.3 Valneva Veterinary Vaccines Products and Services
11.20.4 Valneva Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022)
11.20.5 Valneva Recent Developments
11.21 Vetoquinol
11.21.1 Vetoquinol Company Details
11.21.2 Vetoquinol Business Overview
11.21.3 Vetoquinol Veterinary Vaccines Products and Services
11.21.4 Vetoquinol Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022)
11.21.5 Vetoquinol Recent Developments
11.22 Virbac
11.22.1 Virbac Company Details
11.22.2 Virbac Business Overview
11.22.3 Virbac Veterinary Vaccines Products and Services
11.22.4 Virbac Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022)
11.22.5 Virbac Recent Developments
12 Veterinary Vaccines Market Dynamics
12.1 Veterinary Vaccines Market Trends
12.2 Veterinary Vaccines Market Drivers
12.3 Veterinary Vaccines Market Challenges
12.4 Veterinary Vaccines Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
    Table 1. Global Veterinary Vaccines Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Inactivated Vaccines
    Table 3. Key Players of Live Attenuated Vaccines
    Table 4. Key Players of Conjugate Vaccines
    Table 5. Key Players of Toxoid Vaccines
    Table 6. Key Players of Recombinant Vaccines
    Table 7. Key Players of DNA Vaccines
    Table 8. Key Players of Others
    Table 9. Global Veterinary Vaccines Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 10. Global Veterinary Vaccines Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
    Table 11. Global Veterinary Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Veterinary Vaccines Revenue Market Share by Region (2017-2022)
    Table 13. Global Veterinary Vaccines Revenue by Players (2017-2022) & (US$ Million)
    Table 14. Global Veterinary Vaccines Market Share by Players (2017-2022)
    Table 15. Global Top Veterinary Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Vaccines as of 2021)
    Table 16. Ranking of Global Top Veterinary Vaccines Companies by Revenue (US$ Million) in 2021
    Table 17. Global 5 Largest Players Market Share by Veterinary Vaccines Revenue (CR5 and HHI) & (2017-2022)
    Table 18. Key Players Headquarters and Area Served
    Table 19. Key Players Veterinary Vaccines Product Solution and Service
    Table 20. Date of Key Manufacturers Enter into Veterinary Vaccines Market
    Table 21. Mergers & Acquisitions, Expansion Plans
    Table 22. Global Veterinary Vaccines Market Size by Type (2017-2022) & (US$ Million)
    Table 23. Global Veterinary Vaccines Revenue Market Share by Type (2017-2022)
    Table 24. Global Veterinary Vaccines Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 25. Global Veterinary Vaccines Revenue Market Share by Type (2023-2028)
    Table 26. Global Veterinary Vaccines Market Size by Application (2017-2022) & (US$ Million)
    Table 27. Global Veterinary Vaccines Revenue Market Share by Application (2017-2022)
    Table 28. Global Veterinary Vaccines Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 29. Global Veterinary Vaccines Revenue Market Share by Application (2023-2028)
    Table 30. North America Veterinary Vaccines Revenue by Company (2020-2022) & (US$ Million)
    Table 31. North America Veterinary Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 32. North America Veterinary Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 33. North America Veterinary Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 34. North America Veterinary Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 35. North America Veterinary Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 36. North America Veterinary Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 37. Europe Veterinary Vaccines Revenue by Company (2020-2022) & (US$ Million)
    Table 38. Europe Veterinary Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 39. Europe Veterinary Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 40. Europe Veterinary Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Europe Veterinary Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Europe Veterinary Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 43. Europe Veterinary Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Veterinary Vaccines Revenue by Company (2020-2022) & (US$ Million)
    Table 45. Asia Pacific Veterinary Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Veterinary Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Veterinary Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Veterinary Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Veterinary Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Veterinary Vaccines Revenue by Region (2023-2028) & (US$ Million)
    Table 51. Latin America Veterinary Vaccines Revenue by Company (2020-2022) & (US$ Million)
    Table 52. Latin America Veterinary Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 53. Latin America Veterinary Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 54. Latin America Veterinary Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 55. Latin America Veterinary Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 56. Latin America Veterinary Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 57. Latin America Veterinary Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Veterinary Vaccines Revenue by Company (2020-2022) & (US$ Million)
    Table 59. Middle East and Africa Veterinary Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Veterinary Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Veterinary Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Veterinary Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 63. Middle East and Africa Veterinary Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 64. Middle East and Africa Veterinary Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 65. Elanco Company Details
    Table 66. Elanco Business Overview
    Table 67. Elanco Veterinary Vaccines Product and Services
    Table 68. Elanco Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 69. Elanco Veterinary Vaccines SWOT Analysis
    Table 70. Elanco Recent Developments
    Table 71. Merck Company Details
    Table 72. Merck Business Overview
    Table 73. Merck Veterinary Vaccines Product and Services
    Table 74. Merck Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 75. Merck Veterinary Vaccines SWOT Analysis
    Table 76. Merck Recent Developments
    Table 77. Merial Company Details
    Table 78. Merial Business Overview
    Table 79. Merial Veterinary Vaccines Product and Services
    Table 80. Merial Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 81. Merial Veterinary Vaccines SWOT Analysis
    Table 82. Merial Recent Developments
    Table 83. Zoetis Company Details
    Table 84. Zoetis Business Overview
    Table 85. Zoetis Veterinary Vaccines Product and Services
    Table 86. Zoetis Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 87. Zoetis Veterinary Vaccines SWOT Analysis
    Table 88. Zoetis Recent Developments
    Table 89. Advaxis Company Details
    Table 90. Advaxis Business Overview
    Table 91. Advaxis Veterinary Vaccines Product and Services
    Table 92. Advaxis Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 93. Advaxis Veterinary Vaccines SWOT Analysis
    Table 94. Advaxis Recent Developments
    Table 95. AmpliPhi Biosciences Company Details
    Table 96. AmpliPhi Biosciences Business Overview
    Table 97. AmpliPhi Biosciences Veterinary Vaccines Product and Services
    Table 98. AmpliPhi Biosciences Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 99. AmpliPhi Biosciences Veterinary Vaccines SWOT Analysis
    Table 100. AmpliPhi Biosciences Recent Developments
    Table 101. Aratana Therapeutics Company Details
    Table 102. Aratana Therapeutics Business Overview
    Table 103. Aratana Therapeutics Veterinary Vaccines Product and Services
    Table 104. Aratana Therapeutics Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 105. Aratana Therapeutics Veterinary Vaccines SWOT Analysis
    Table 106. Aratana Therapeutics Recent Developments
    Table 107. ARKO Labs Company Details
    Table 108. ARKO Labs Business Overview
    Table 109. ARKO Labs Veterinary Vaccines Product and Services
    Table 110. ARKO Labs Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 111. ARKO Labs Veterinary Vaccines SWOT Analysis
    Table 112. ARKO Labs Recent Developments
    Table 113. Bayer Company Details
    Table 114. Bayer Business Overview
    Table 115. Bayer Veterinary Vaccines Product and Services
    Table 116. Bayer Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 117. Bayer Veterinary Vaccines SWOT Analysis
    Table 118. Bayer Recent Developments
    Table 119. CanFel Therapeutics Company Details
    Table 120. CanFel Therapeutics Business Overview
    Table 121. CanFel Therapeutics Veterinary Vaccines Product and Services
    Table 122. CanFel Therapeutics Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 123. CanFel Therapeutics Veterinary Vaccines SWOT Analysis
    Table 124. CanFel Therapeutics Recent Developments
    Table 125. Ceva Animal Health Company Details
    Table 126. Ceva Animal Health Business Overview
    Table 127. Ceva Animal Health Veterinary Vaccines Product and Services
    Table 128. Ceva Animal Health Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 129. Ceva Animal Health Recent Developments
    Table 130. Colorado Serum Company Details
    Table 131. Colorado Serum Business Overview
    Table 132. Colorado Serum Veterinary Vaccines Product and Services
    Table 133. Colorado Serum Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 134. Colorado Serum Recent Developments
    Table 135. Epitopix Company Details
    Table 136. Epitopix Business Overview
    Table 137. Epitopix Veterinary Vaccines Product and Services
    Table 138. Epitopix Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 139. Epitopix Recent Developments
    Table 140. Genus Company Details
    Table 141. Genus Business Overview
    Table 142. Genus Veterinary Vaccines Product and Services
    Table 143. Genus Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 144. Genus Recent Developments
    Table 145. Hygieia Biological Laboratories Company Details
    Table 146. Hygieia Biological Laboratories Business Overview
    Table 147. Hygieia Biological Laboratories Veterinary Vaccines Product and Services
    Table 148. Hygieia Biological Laboratories Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 149. Hygieia Biological Laboratories Recent Developments
    Table 150. ImmuCell Company Details
    Table 151. ImmuCell Business Overview
    Table 152. ImmuCell Veterinary Vaccines Product and Services
    Table 153. ImmuCell Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 154. ImmuCell Recent Developments
    Table 155. Nexvet Company Details
    Table 156. Nexvet Business Overview
    Table 157. Nexvet Veterinary Vaccines Product and Services
    Table 158. Nexvet Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 159. Nexvet Recent Developments
    Table 160. Nuovo Biologics Company Details
    Table 161. Nuovo Biologics Business Overview
    Table 162. Nuovo Biologics Veterinary Vaccines Product and Services
    Table 163. Nuovo Biologics Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 164. Nuovo Biologics Recent Developments
    Table 165. UBI Company Details
    Table 166. UBI Business Overview
    Table 167. UBI Veterinary Vaccines Product and Services
    Table 168. UBI Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 169. UBI Recent Developments
    Table 170. Valneva Company Details
    Table 171. Valneva Business Overview
    Table 172. Valneva Veterinary Vaccines Product and Services
    Table 173. Valneva Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 174. Valneva Recent Developments
    Table 175. Vetoquinol Company Details
    Table 176. Vetoquinol Business Overview
    Table 177. Vetoquinol Veterinary Vaccines Product and Services
    Table 178. Vetoquinol Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 179. Vetoquinol Recent Developments
    Table 180. Virbac Company Details
    Table 181. Virbac Business Overview
    Table 182. Virbac Veterinary Vaccines Product and Services
    Table 183. Virbac Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million)
    Table 184. Virbac Recent Developments
    Table 185. Veterinary Vaccines Market Trends
    Table 186. Veterinary Vaccines Market Drivers
    Table 187. Veterinary Vaccines Market Challenges
    Table 188. Veterinary Vaccines Market Restraints
    Table 189. Research Programs/Design for This Report
    Table 190. Key Data Information from Secondary Sources
    Table 191. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Veterinary Vaccines Sales Market Share by Type: 2021 VS 2028
    Figure 2. Inactivated Vaccines Features
    Figure 3. Live Attenuated Vaccines Features
    Figure 4. Conjugate Vaccines Features
    Figure 5. Toxoid Vaccines Features
    Figure 6. Recombinant Vaccines Features
    Figure 7. DNA Vaccines Features
    Figure 8. Others Features
    Figure 9. Global Veterinary Vaccines Sales Market Share by Application: 2021 VS 2028
    Figure 10. Veterinary Clinic Case Studies
    Figure 11. Veterinary Hospital Case Studies
    Figure 12. Veterinary Research Institute Case Studies
    Figure 13. Retail Pharmacy Case Studies
    Figure 14. Others Case Studies
    Figure 15. Veterinary Vaccines Report Years Considered
    Figure 16. Global Veterinary Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 17. Global Veterinary Vaccines Market Size 2017-2028 (US$ Million)
    Figure 18. Global Veterinary Vaccines Market Size Market Share by Region: 2021 VS 2028
    Figure 19. Global Veterinary Vaccines Revenue Market Share by Region in 2017 VS 2022
    Figure 20. Global Top 10 Veterinary Vaccines Countries Ranking by Market Size (US$ Million) in 2021
    Figure 21. Global Veterinary Vaccines Market Share by Players in 2021
    Figure 22. Global Top Veterinary Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Vaccines as of 2021)
    Figure 23. The Top 10 and 5 Players Market Share by Veterinary Vaccines Revenue in 2021
    Figure 24. North America Veterinary Vaccines Revenue Market Share by Company in 2021
    Figure 25. North America Veterinary Vaccines Revenue Market Share by Type (2017-2028)
    Figure 26. North America Veterinary Vaccines Revenue Market Share by Application (2017-2028)
    Figure 27. North America Veterinary Vaccines Revenue Share by Country (2017-2028)
    Figure 28. U.S. Veterinary Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 29. Canada Veterinary Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 30. Europe Veterinary Vaccines Revenue Market Share by Company in 2021
    Figure 31. Europe Veterinary Vaccines Revenue Market Share by Type (2017-2028)
    Figure 32. Europe Veterinary Vaccines Revenue Market Share by Application (2017-2028)
    Figure 33. Europe Veterinary Vaccines Revenue Share by Country (2017-2028)
    Figure 34. Germany Veterinary Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 35. France Veterinary Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 36. U.K. Veterinary Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 37. Italy Veterinary Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 38. Russia Veterinary Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 39. Asia Pacific Veterinary Vaccines Revenue Market Share by Company in 2021
    Figure 40. Asia Pacific Veterinary Vaccines Revenue Market Share by Type (2017-2028)
    Figure 41. Asia Pacific Veterinary Vaccines Revenue Market Share by Application (2017-2028)
    Figure 42. Asia Pacific Veterinary Vaccines Revenue Share by Region (2017-2028)
    Figure 43. China Veterinary Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 44. Japan Veterinary Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 45. South Korea Veterinary Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 46. India Veterinary Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 47. Australia Veterinary Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 48. Taiwan Veterinary Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 49. Indonesia Veterinary Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 50. Thailand Veterinary Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 51. Malaysia Veterinary Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 52. Philippines Veterinary Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 53. Vietnam Veterinary Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 54. Latin America Veterinary Vaccines Revenue Market Share by Company in 2021
    Figure 55. Latin America Veterinary Vaccines Revenue Market Share by Type (2017-2028)
    Figure 56. Latin America Veterinary Vaccines Revenue Market Share by Application (2017-2028)
    Figure 57. Latin America Veterinary Vaccines Revenue Share by Country (2017-2028)
    Figure 58. Mexico Veterinary Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 59. Brazil Veterinary Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 60. Argentina Veterinary Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 61. Middle East and Africa Veterinary Vaccines Revenue Market Share by Company in 2021
    Figure 62. Middle East and Africa Veterinary Vaccines Revenue Market Share by Type (2017-2028)
    Figure 63. Middle East and Africa Veterinary Vaccines Revenue Market Share by Application (2017-2028)
    Figure 64. Middle East and Africa Veterinary Vaccines Revenue Share by Country (2017-2028)
    Figure 65. Turkey Veterinary Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 66. Saudi Arabia Veterinary Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 67. U.A.E Veterinary Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 68. Elanco Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 69. Merck Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 70. Merial Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 71. Zoetis Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 72. Advaxis Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 73. AmpliPhi Biosciences Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 74. Aratana Therapeutics Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 75. ARKO Labs Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 76. Bayer Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 77. CanFel Therapeutics Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 78. Ceva Animal Health Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 79. Colorado Serum Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 80. Epitopix Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 81. Genus Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 82. Hygieia Biological Laboratories Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 83. ImmuCell Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 84. Nexvet Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 85. Nuovo Biologics Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 86. UBI Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 87. Valneva Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 88. Vetoquinol Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 89. Virbac Revenue Growth Rate in Veterinary Vaccines Business (2017-2022)
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5600

This license allows only one user to access the PDF.
Electronic (PDF)

$8400

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11200

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS